<?xml version="1.0" encoding="UTF-8"?>
<p id="p0320">
 <bold>Product stability and storage</bold>: The minimally acceptable target “Shelf life of at least 12 months at −20 °C, and demonstration of at least 1 month stability at 2–8 °C” should be expanded to allow for frozen liquid vaccine held at &lt; -60 °C, given recent experience with distribution of Ervebo® (Ebola) vaccine during epidemics in Africa.
</p>
